Divi's Laboratories Limited (IN:DIVISLAB)
:DIVISLAB
Want to see IN:DIVISLAB full AI Analyst Report?
Total Valuation
Divi's Laboratories Limited has a market cap or net worth of ₹1.77T. The enterprise value is ₹1.74T.
Market Cap₹1.77T
Enterprise Value₹1.74T
Share Statistics
Divi's Laboratories Limited has 265,468,570 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding265,468,570
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Divi's Laboratories Limited’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 12.55%.
Return on Equity (ROE)0.15
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)12.55%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee10.84M
Profits Per Employee2.64M
Employee Count9,741
Asset Turnover0.53
Inventory Turnover1.52
Valuation Ratios
The current PE Ratio of Divi's Laboratories Limited is 68.8. Divi's Laboratories Limited’s PEG ratio is 3.57.
PE Ratio68.8
PS Ratio14.95
PB Ratio9.42
Price to Fair Value9.42
Price to FCF317.60
Price to Operating Cash Flow107.33
PEG Ratio3.57
Income Statement
In the last 12 months, Divi's Laboratories Limited had revenue of 105.60B and earned 25.68B in profits. Earnings per share was 96.75.
Revenue105.60B
Gross Profit45.62B
Operating Income29.78B
Pretax Income33.88B
Net Income25.68B
EBITDA38.74B
Earnings Per Share (EPS)96.75
Cash Flow
In the last 12 months, operating cash flow was 16.45B and capital expenditures -15.44B, giving a free cash flow of 1.01B billion.
Operating Cash Flow16.45B
Free Cash Flow1.01B
Free Cash Flow per Share3.80
Dividends & Yields
Divi's Laboratories Limited pays an annual dividend of ₹30, resulting in a dividend yield of 0.46%
Dividend Per Share₹30
Dividend Yield0.46%
Payout Ratio32.06%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.75
52-Week Price Change0.17%
50-Day Moving Average6.47K
200-Day Moving Average6.33K
Relative Strength Index (RSI)51.02
Average Volume (3m)6.36K
Important Dates
Divi's Laboratories Limited upcoming earnings date is Aug 3, 2026, TBA (Confirmed).
Last Earnings DateMay 23, 2026
Next Earnings DateAug 3, 2026
Ex-Dividend Date―
Financial Position
Divi's Laboratories Limited as a current ratio of 5.43, with Debt / Equity ratio of 0.04%
Current Ratio5.43
Quick Ratio3.50
Debt to Market Cap0.00
Net Debt to EBITDA-0.99
Interest Coverage Ratio129.48
Taxes
In the past 12 months, Divi's Laboratories Limited has paid 8.20B in taxes.
Income Tax8.20B
Effective Tax Rate0.24
Enterprise Valuation
Divi's Laboratories Limited EV to EBITDA ratio is 44.88, with an EV/FCF ratio of 310.75.
EV to Sales14.63
EV to EBITDA44.88
EV to Free Cash Flow310.75
EV to Operating Cash Flow51.19
Balance Sheet
Divi's Laboratories Limited has ₹32.61B in cash and marketable securities with ₹900.00M in debt, giving a net cash position of ₹31.71B billion.
Cash & Marketable Securities₹32.61B
Total Debt₹900.00M
Net Cash₹31.71B
Net Cash Per Share₹119.45
Tangible Book Value Per Share₹631.48
Margins
Gross margin is 52.07%, with operating margin of 28.20%, and net profit margin of 24.32%.
Gross Margin52.07%
Operating Margin28.20%
Pretax Margin32.08%
Net Profit Margin24.32%
EBITDA Margin32.59%
EBIT Margin28.20%
Analyst Forecast
The average price target for Divi's Laboratories Limited is ₹7,717.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹7,717.50
Price Target Upside16.88% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast12.82%
EPS Growth Forecast17.23%